Vasodilation Effects
Vasodilation Effects - Related Videos
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
0 Views •
Cited by 165 •
2010
A noninvasive procedure to assess endothelial function is demonstrated using the Endo-PAT 2000.
08:09
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
0 Views •
Cited by 1 •
2017
We describe the isolation of cardiac extracellular matrix from C57Bl/6J control mice, tight-skin mice, and tight-skin mice treated with the IRF5 inhibitory peptide. We also describe the vasodilation studies on the isolated vessels from C57Bl/6J, tight-skin mice and tight-skin mice treated with the IRF5 inhibitory peptide.
01:23
Antihypertensive Drugs: Vasodilators
0 Views •
2024
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
08:42
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
0 Views •
Cited by 42 •
2014
Endothelial dysfunction is associated with numerous disease states and is predictive of adverse cardiovascular events in humans. Flow-mediated vasodilation (FMD) is a non-invasive ultrasound method of evaluating endothelial function. Methodological choices and operator experience may affect results. A systematic approach to FMD in human studies is discussed here.
02:19
Buffer Effectiveness
0 Views •
2020
Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised. The buffer capacity is the amount of acid or base that can be added to a given volume...
FAQs
Nitric oxide contributes to relaxation through a pathway involving cyclic guanosine monophosphate, or cGMP. This signaling system changes the contractile state of vascular smooth muscle, allowing the vessel to widen. The resulting reduction in vascular resistance can improve blood flow and lower blood pressure, which explains why this pathway is important in pharmacological treatment.
Calcium signaling helps regulate contraction in vascular smooth muscle, so changes in this process can promote relaxation. Some drugs act more directly on the muscle cells rather than primarily using nitric oxide and cGMP pathways. These distinct mechanisms give pharmacology several ways to influence vascular tone, blood flow, resistance, and blood pressure.
Widening blood vessels can produce noticeable systemic effects, including headache, flushing, and dizziness. A fall in vascular resistance or blood pressure may also trigger a reflex increase in heart rate. These responses are important when interpreting the effects of vasodilator medicines because the desired circulatory action can occur alongside compensatory or uncomfortable reactions.
By increasing blood flow, vessel widening can support tissue perfusion, meaning delivery of blood to tissues. Lower vascular resistance can also reduce the workload placed on the heart. This relationship connects vascular smooth muscle responses with broader circulatory outcomes and helps explain the therapeutic value of vasodilator medicines in disorders where blood pressure or cardiac workload requires control.
In pharmacology, vasodilator medicines are used to manage hypertension, angina, heart failure, and other circulatory disorders. Their relevance differs by the circulatory problem being addressed, but the shared therapeutic goal is to alter vascular resistance, blood flow, blood pressure, or cardiac workload. Understanding the underlying mechanism helps relate a drug's action to these clinical applications.
Evaluation should include both intended and unwanted circulatory outcomes. Relevant effects include changes in tissue blood flow, vascular resistance, blood pressure, and cardiac workload, together with symptoms such as headache, flushing, or dizziness. Researchers and clinicians should also consider whether a reflex increase in heart rate accompanies the vascular response, since that response can influence overall treatment effects.